O
Ossur hf
CSE:OSSR
Ossur hf
CSE:OSSR
Price:
26.4
DKK
-2.22%
Market Cap:
kr11.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Ossur hf
CSE:OSSR
|
IS |
|
P
|
Paradise Co Ltd
KOSDAQ:034230
|
KR |
|
D
|
Dream Residential Real Estate Investment Trust
TSX:DRR.U
|
CA |
|
A
|
Aesthetic Connect PCL
SET:TRP
|
TH |
|
First Resource Bank (Pennsylvania)
OTC:FRSB
|
US |
|
Robot Home Inc
TSE:1435
|
JP |
|
Ser Educacional SA
BOVESPA:SEER3
|
BR |
|
Fiserv Inc
NASDAQ:FISV
|
US |
|
Kesar Terminals & Infrastructure Ltd
BSE:533289
|
IN |
|
A
|
Allianz SE
OTC:ALIZY
|
DE |
|
N
|
Nouveau Global Ventures Ltd
BSE:531465
|
IN |
|
Investigator Resources Ltd
ASX:IVR
|
AU |
|
Dr Martens PLC
LSE:DOCS
|
UK |
|
Cathedra Bitcoin Inc
XTSX:CBIT
|
CA |
|
Bank Panin Dubai Syariah Tbk PT
IDX:PNBS
|
ID |
|
A
|
ASP Isotopes Inc
NASDAQ:ASPI
|
US |
|
B
|
Buriram Sugar PCL
SET:BRR
|
TH |
|
M
|
Myanmar Investments International Ltd
LSE:MIL
|
SG |
|
T
|
Techno Medical PCL
SET:TM
|
TH |
|
A
|
Asian Alliance International PCL
SET:AAI
|
TH |
Relative Value
There is not enough data to reliably calculate the relative value of OSSR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OSSR
Relative Value
Base Case
Not Available
Multiples Across Competitors
OSSR Competitors Multiples
Ossur hf Competitors
Ossur hf Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IS |
O
|
Ossur hf
CSE:OSSR
|
11.3B DKK | 2.2 | 31.2 | 16.4 | 24.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182B USD | 4.1 | 27.9 | 16 | 22 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.9B USD | 16.6 | 58.4 | 44.3 | 54.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 5 | 38.6 | 19.8 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 35.7 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.5B EUR | 1.8 | 19.3 | 10.9 | 15.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 7.9 | 44.8 | 24.6 | 27 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.9B USD | 10.7 | 43.3 | 30.7 | 34 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 2.1 | 25.7 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
